VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,625 | -65.2% | 3,802 | -9.0% | 0.02% | -63.9% |
| Q2 2023 | $102,511 | +12.8% | 4,179 | +7.0% | 0.06% | +22.0% |
| Q1 2023 | $90,869 | -33.6% | 3,905 | -27.8% | 0.05% | -29.6% |
| Q4 2022 | $136,876 | +50.4% | 5,408 | +15.2% | 0.07% | +97.2% |
| Q3 2022 | $91,000 | -23.5% | 4,695 | +0.8% | 0.04% | -18.2% |
| Q2 2022 | $119,000 | +36.8% | 4,659 | +38.1% | 0.04% | +12.8% |
| Q1 2022 | $87,000 | -41.6% | 3,374 | -5.4% | 0.04% | -30.4% |
| Q4 2021 | $149,000 | -26.6% | 3,568 | -23.5% | 0.06% | -37.1% |
| Q3 2021 | $203,000 | -12.5% | 4,664 | -5.0% | 0.09% | -6.3% |
| Q2 2021 | $232,000 | -50.8% | 4,912 | -46.7% | 0.10% | -52.3% |
| Q1 2021 | $472,000 | +95.0% | 9,214 | +1.9% | 0.20% | +99.0% |
| Q4 2020 | $242,000 | -21.7% | 9,044 | +0.5% | 0.10% | -38.3% |
| Q3 2020 | $309,000 | -26.3% | 9,001 | -12.0% | 0.16% | -18.2% |
| Q2 2020 | $419,000 | – | 10,226 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |